Elanco Animal Health (ELAN)
NYSE: ELAN
· Real-Time Price · USD
17.95
-0.05 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
17.96
0.08%
After-hours: Aug 15, 2025, 06:16 PM EDT
Elanco Animal Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.24B | 1.19B | 1.02B | 1.03B | 1.18B | 1.21B | 1.03B | 1.07B | 1.06B | 1.26B | 988M | 1.03B | 1.18B | 1.23B | 1.11B | 1.13B | 1.28B | 1.24B |
Cost of Revenue | 664M | 509M | 501M | 625M | 626M | 515M | 516M | 487M | 434M | 494M | 448M | 472M | 484M | 509M | 512M | 502M | 551M | 569M |
Gross Profit | 577M | 684M | 389M | 405M | 558M | 690M | 519M | 581M | 623M | 763M | 540M | 556M | 693M | 716M | 601M | 629M | 728M | 673M |
Operating Income | 85M | 121M | 8M | -5M | 115M | 133M | -24M | 42M | 53M | 212M | 6M | 44M | 135M | 169M | -66M | 52M | 120M | 89M |
Interest Income | 11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 25M | 60M | -51M | 559M | -32M | 12M | -127M | -1.1B | -79M | 108M | -88M | -42M | -18M | 71M | -121M | -130M | -236M | -80M |
Net Income | 11M | 67M | -8M | 364M | -50M | 32M | -141M | -1.1B | -97M | 103M | -54M | -49M | -22M | 51M | -97M | -104M | -210M | -61M |
Selling & General & Admin | 400M | 341M | 300M | 323M | 354M | 337M | 292M | 313M | 353M | 327M | 303M | 298M | 343M | 320M | 329M | 342M | 385M | 348M |
Research & Development | 92M | 94M | 81M | 87M | 89M | 87M | 79M | 86M | 81M | 81M | 80M | 78M | 82M | 81M | 92M | 94M | 94M | 89M |
Other Expenses | n/a | 128M | n/a | n/a | -2M | -9M | -34M | -9M | -23M | 134M | 130M | 128M | 133M | 137M | 3M | -11M | 3M | 147M |
Operating Expenses | 492M | 563M | 381M | 410M | 443M | 557M | 509M | 539M | 570M | 542M | 513M | 504M | 558M | 538M | 560M | 577M | 608M | 584M |
Interest Expense | 70M | 40M | 46M | 58M | 65M | 66M | 67M | 72M | 74M | 64M | 62M | 60M | 67M | 52M | 55M | 60M | 60M | 61M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 207M | n/a | n/a | n/a | 201M | n/a | n/a | n/a | 248M | n/a | n/a | n/a |
Cost & Expenses | 1.16B | 1.07B | 1.01B | 1.03B | 1.07B | 1.07B | 1.02B | 1.03B | 1B | 1.04B | 961M | 976M | 1.04B | 1.05B | 1.07B | 1.08B | 1.16B | 1.15B |
Income Tax Expense | 14M | -7M | -43M | 195M | 18M | -20M | 14M | -1M | 18M | 5M | -34M | 7M | 4M | 23M | -24M | -26M | -26M | -19M |
Shares Outstanding (Basic) | 496.6M | 495.1M | 494.4M | 494.3M | 494.2M | 493.2M | 492.8M | 492.7M | 492.6M | 491.1M | 488.5M | 488.4M | 488.4M | 488M | 487.4M | 487.3M | 487.3M | 486.7M |
Shares Outstanding (Diluted) | 500.1M | 499.1M | 494.4M | 497.7M | 494.2M | 496M | 492.8M | 492.7M | 492.6M | 492.8M | 488.5M | 488.4M | 488.4M | 492.2M | 487.4M | 487.3M | 487.3M | 486.7M |
EPS (Basic) | 0.02 | 0.14 | -0.02 | 0.74 | -0.1 | 0.06 | -0.29 | -2.22 | -0.2 | 0.21 | -0.11 | -0.1 | -0.04 | 0.10 | -0.2 | -0.21 | -0.43 | -0.13 |
EPS (Diluted) | 0.02 | 0.13 | -0.02 | 0.73 | -0.1 | 0.06 | -0.29 | -2.22 | -0.2 | 0.21 | -0.11 | -0.1 | -0.04 | 0.10 | -0.2 | -0.21 | -0.43 | -0.13 |
EBITDA | 264M | 261M | 175M | 787M | 195M | 299M | 111M | -852M | 230M | 394M | 146M | 217M | 304M | 352M | 114M | 100M | 293M | 293M |
EBIT | 95M | 100M | -5M | 617M | 33M | 133M | -60M | -1.02B | -5M | 172M | -23M | 16M | 53M | 127M | -60M | 54M | -176M | -19M |
Depreciation & Amortization | 169M | 161M | 164M | 170M | 162M | 166M | 171M | 173M | 177M | 173M | 169M | 167M | 171M | 176M | 174M | 170M | 170M | 202M |